Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLA: Celecoxib in LAM and TSC
NCT02484664Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in lymphangioleiomyomatosis (LAM), sponsored by Brigham and Women's Hospital. Started Jun 2016; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
lymphangioleiomyomatosis (LAM)
Beyond the preview
Go deeper on NCT02484664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02484664.